Publication

Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study.

Journal Paper/Review - Jul 25, 2024

Fleischmann Roy, Meerwein Sebastian, Charles-Schoeman Christina, Combe Bernard, Hall Stephen, Khan Nasser, Carter Kyle M, Camp Heidi S, Rubbert-Roth Andrea